Insider: The CEO & President of Petmed Express Inc (NASDAQ:PETS), Menderes Akdag Sold 3,726 Shares

November 23, 2016 - By Peter Erickson

Insider: The CEO & President of Petmed Express Inc (NASDAQ:PETS), Menderes Akdag Sold 3,726 Shares

Menderes Akdag Insider Sell

It was shown in a public document filed with the Security and Exchange Commission that Menderes Akdag, who works for Petmed Express Inc, and is currently the CEO & President made an insider deal on November 23, 2016. He sold 3,726 shares of the corporation at an average $22.3 U.S. Dollars for every share. As disclosed in the document available for free here, the total amount of the deal was $82,904 U.S. Dollars. It seems he is very active lately as in the last month, he sold additional 40,000 shares of the company, worth $865,000 USD. Menderes Akdag holds around 2.75% of Petmed Express Inc’s total market capitalization or 556,274 shares.

Petmed Express Inc (NASDAQ:PETS) Ratings Coverage

Out of 2 analysts covering Petmed Express Inc (NASDAQ:PETS), 0 rate it a “Buy”, 1 “Sell”, while 1 “Hold”. This means 0 are positive. Petmed Express Inc has been the topic of 2 analyst reports since February 4, 2016 according to StockzIntelligence Inc. The stock of Petmed Express Inc (NASDAQ:PETS) has “Underperform” rating given on Thursday, February 4 by Credit Suisse. Craig Hallum upgraded Petmed Express Inc (NASDAQ:PETS) on Monday, May 9 to “Hold” rating.

Insitutional Activity: The institutional sentiment increased to 1.03 in Q2 2016. Its up 0.15, from 0.88 in 2016Q1. The ratio is positive, as 17 funds sold all Petmed Express Inc shares owned while 51 reduced positions. 19 funds bought stakes while 41 increased positions. They now own 14.80 million shares or 6.13% less from 15.76 million shares in 2016Q1.

Teachers Retirement Systems Of The State Of Kentucky has 6,900 shares for 0% of their US portfolio. The New York-based Blackrock has invested 0% in Petmed Express Inc (NASDAQ:PETS). Principal Fincl Group Inc, a Iowa-based fund reported 143,304 shares. Gemmer Asset Limited Com has invested 0% of its portfolio in Petmed Express Inc (NASDAQ:PETS). Advsrs Asset owns 165,940 shares or 0.05% of their US portfolio. C M Bidwell Associates Limited owns 9,495 shares or 0.04% of their US portfolio. Allianz Asset Mngmt Ag accumulated 215,159 shares or 0% of the stock. Alps Advisors accumulated 0% or 22,727 shares. Amer Intl Grp last reported 0% of its portfolio in the stock. Prudential Public Limited Company holds 0% or 20,535 shares in its portfolio. Park Circle accumulated 0.41% or 30,000 shares. Moreover, Schwab Charles has 0% invested in Petmed Express Inc (NASDAQ:PETS) for 59,370 shares. Pub Sector Pension Inv Board, a Quebec – Canada-based fund reported 13,992 shares. Royal Commercial Bank Of Canada holds 6,423 shares or 0% of its portfolio. Moreover, Gsa Cap Limited Liability Partnership has 0.09% invested in Petmed Express Inc (NASDAQ:PETS) for 90,220 shares.

Insider Transactions: Since August 8, 2016, the stock had 0 insider buys, and 9 sales for $1.91 million net activity. AKDAG MENDERES had sold 10,000 shares worth $207,500 on Thursday, September 22. 4,500 shares were sold by SCHWEITZER ROBERT C, worth $92,355. ROSENBLOOM BRUCE S sold $163,040 worth of stock. $217,500 worth of Petmed Express Inc (NASDAQ:PETS) was sold by FORMICA FRANK J.

About 85,973 shares traded hands. Petmed Express Inc (NASDAQ:PETS) has risen 21.83% since April 21, 2016 and is uptrending. It has outperformed by 16.50% the S&P500.

PetMed Express, Inc. , doing business as 1800PetMeds, is a pet pharmacy. The company has a market cap of $450.97 million. The Firm markets prescription and non-prescription pet medications, and other health products for dogs and cats, direct to the consumer. It has a 20.5 P/E ratio. It offers a selection of products for dogs and cats.

According to Zacks Investment Research, “Petmed Express is America’s largest pet pharmacy, delivering prescription and non-prescription pet medications and health and nutritional supplements for dogs and cats at competitive prices direct to the consumer through its 1-800-PetMeds toll free number and on the Internet.”

Analysts await Petmed Express Inc (NASDAQ:PETS) to report earnings on January, 23. They expect $0.24 EPS, 0.00% or $0.00 from last year’s $0.24 per share. PETS’s profit will be $4.92M for 22.91 P/E if the $0.24 EPS becomes a reality. After $0.24 actual EPS reported by Petmed Express Inc for the previous quarter, Wall Street now forecasts 0.00% EPS growth.

More news for Petmed Express Inc (NASDAQ:PETS) were recently published by: Quotes.Wsj.com, which released: “News PetMed Express Inc.PETS” on February 12, 2011. Nasdaq.com‘s article titled: “Earnings Reaction History: PetMed Express, Inc., 25.0% Follow-Through ..” and published on October 24, 2016 is yet another important article.

PETS Company Profile

PetMed Express, Inc. (PetMed Express), doing business as 1800PetMeds, incorporated on January 3, 1997, is a pet pharmacy. The Firm markets prescription and non-prescription pet medications, and other health products for dogs and cats, direct to the consumer. The Firm offers a selection of products for dogs and cats. The Company’s product line contains approximately 3,000 stock keeping units (SKUS) of pet medications, health products and supplies.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Tags: , ,

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>